Filing a DMF for Onamer(R) M, Polyquaternium-1 with the U.S. FDA
Filing a drug master file (DMF) for Onamer(R) M, Polyquaternium-1 can be a useful mechanism to market your
Onamer(R) M, Polyquaternium-1 to the U.S. Drug Industry. Typical Onamer(R) M, Polyquaternium-1 producers who have filed a DMF for
Onamer(R) M, Polyquaternium-1 include:
-
Stepan Co
Registrar Corp can help you to properly prepare and submit your Onamer(R) M, Polyquaternium-1 DMF to FDA.
As your Agent, Registrar Corp will perform the following administrative functions:
-
Format, assemble and deliver your Onamer(R) M, Polyquaternium-1 DMF to FDA
-
Submit letters of authorization regarding your Onamer(R) M, Polyquaternium-1 to FDA
-
Provide changes, additions and maintenance of your Onamer(R) M, Polyquaternium-1 DMF
-
Respond to issues relating to ownership of your Onamer(R) M, Polyquaternium-1 DMF
-
Assist with submission of responses to FDA concerning your Onamer(R) M, Polyquaternium-1 DMF
-
Perform any required annual updates for your Onamer(R) M, Polyquaternium-1 DMF
For more information about filing a DMF for Onamer(R) M, Polyquaternium-1, simply click below:
U.S. FDA Regulations:
U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
